Paulette Hamilton

I begin by thanking the hon. Member for Wokingham (Clive Jones) for securing this debate and for his tireless work campaigning for better outcomes for all affected by the least survivable cancers. For too long, these cancers have been neglected and left behind. Patients and their loved ones have had to bear the devastating costs alone. As chair of the all-party group on less survivable cancers, I urge the Government to make this a reality by prioritising in their plan the improvement of early diagnosis for these six cancers—brain, lung, oesophagus, pancreas, stomach and liver—which remain some of the toughest to diagnose. For decades, GPs have struggled to identify the vague symptoms linked with these cancers without the necessary diagnostic tools and tech to support early diagnosis. Tragically, this means that more than 70% of patients are diagnosed at an advanced stage and face the heartbreaking news that it is too late. Targeted screening plays a vital role in accelerating early detection and faster diagnosis, as we see through the successes in the NHS lung cancer screening programme. In addition to targeted screening, we want the Government to roll out the nationwide multi-cancer case-finding programme to proactively identify people at high risk of developing cancer. I know personally just how heartbreaking less survivable cancers such as pancreatic cancer can be and the difference that early detection will make. Like many of my colleagues here today, I have seen at first hand the impact of these deadly cancers on individuals, families and loved ones. I lost my best friend in 2021. Pauline was a very vibrant woman who was looking forward to getting married. Later that year, she felt unwell. She had been to the doctor numerous times and no connection was made to cancer. She was busy planning her wedding, but because of her weight loss and continued generalised pain, she went back to the doctor. At that point, they told her that she had stage 4 pancreatic cancer and had eight weeks to live. She lived for six weeks, and then she died. What gives me hope is the transformative role that research can play in driving early diagnosis, such as the new breath test being developed by researchers at Imperial College. As it stands, two in five people with pancreatic cancer are diagnosed quite late—they will see their doctor but not get a diagnosis—and I hope that the Rare Cancers Bill and the national cancer plan will help to drive greater investment in innovation and research. I feel confident that we can deliver bigger breakthroughs and better outcomes across these six cancers. Progress is within our reach. Now it is time to act for all who are and will be affected.